24/7 Market News Snapshot 05 August, 2025 – Fractyl Health, Inc. Common Stock (NASDAQ:GUTS)

August 5, 2025

DENVER, Colo., 05 August, 2025 (www.247marketnews.com) – (NASDAQ:GUTS) are discussed in this article.
Fractyl Health, Inc. (GUTS) has embarked on a remarkable journey, opening at $1.88 and witnessing a considerable surge of 30.48% to trade at $2.427, driven by significant investor interest in the company’s innovative health technology solutions. The trading activity peaked with a volume of 1.80 million shares, underscoring the heightened market participation and signaling potential for ongoing growth. This impressive price uptick reflects growing confidence in Fractyl’s trajectory, suggesting that the company is positioned for further advancements as it forges ahead in the healthcare landscape.

In a significant development, Fractyl Health has published promising two-year follow-up results from its Real-World Registry study concerning the Revita procedure, a non-drug intervention aimed at treating obesity and advanced type 2 diabetes (T2D). The findings reveal a median weight loss of 9.6% and a notable 1.6% reduction in HbA1c levels among participants following the procedure. These results are particularly encouraging for individuals who have struggled to manage their T2D despite being on multiple glucose-lowering medications. With a median participant age of 62, the study demonstrates sustained improvements in weight and metabolic health over two years, with no serious adverse events reported.

Dr. Harith Rajagopalan, Co-Founder and CEO of Fractyl Health, emphasized the importance of these findings, stating that real-world evidence indicates a single Revita procedure can lead to lasting benefits in weight control and metabolic health. As the company anticipates pivotal data from the REMAIN-1 study on Revita’s role in post-GLP-1 therapy weight maintenance, expected by the third quarter of 2025, Fractyl Health’s dedication to revolutionizing metabolic disease treatment remains resolute, striving to provide effective solutions that address the underlying causes of these challenging conditions.

Related news for (GUTS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.